These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3310831)

  • 1. Aluminium in renal disease: current knowledge and future developments.
    Starkey BJ
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():337-44. PubMed ID: 3310831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of aluminium and magnesium effects on initiation and promotion of renal osteodystrophy in patients with chronic renal failure].
    Nakamrua M; Sato N; Tsukamoto Y; Marumo F; Iwanami S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):421-8. PubMed ID: 3747253
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of desferrioximine in dialysis-associated aluminium disease.
    Ackrill P; Day JP
    Contrib Nephrol; 1993; 102():125-34. PubMed ID: 8416177
    [No Abstract]   [Full Text] [Related]  

  • 4. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.
    Felsenfeld AJ
    ANNA J; 1985 Jun; 12(3):189-91. PubMed ID: 3848318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current concepts of the role of aluminum in chronic kidney failure patients].
    Gruev I; Belovezhdov N
    Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspects of aluminum toxicity.
    Hewitt CD; Savory J; Wills MR
    Clin Lab Med; 1990 Jun; 10(2):403-22. PubMed ID: 2197055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiopathology and treatment of chronic kidney failure].
    Marumo F
    Nihon Naika Gakkai Zasshi; 1990 Feb; 79(2):180-4. PubMed ID: 2362151
    [No Abstract]   [Full Text] [Related]  

  • 8. Aluminum load and histological bone disease in hemofiltration and hemodialysis.
    Fournier A; Moriniere P; Fohrer P; Leflon P; de Fremont JF; Marié A; Westeel PF; Renaud H; Tahiri Y; Idrissi A
    Kidney Int Suppl; 1988 Mar; 24():S168-70. PubMed ID: 3163040
    [No Abstract]   [Full Text] [Related]  

  • 9. Aluminum toxicity in children with chronic renal failure.
    Polinsky MS; Gruskin AB
    J Pediatr; 1984 Nov; 105(5):758-61. PubMed ID: 6389807
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Halse J; Flatmark A
    Nephrol Dial Transplant; 1990; 5(6):449-56. PubMed ID: 2122323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term dialysis and its problems: calcium and phosphorus metabolism disorders, aluminum balance, and esteodystrophy].
    Kurokawa K
    Nihon Rinsho; 1980 Jun; 38(6):2329-36. PubMed ID: 6997567
    [No Abstract]   [Full Text] [Related]  

  • 13. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 14. The localization of aluminium and other elements in bone tissue of a case of renal osteodystrophy with an associated dialysis encephalopathy syndrome.
    McClure J; Smith PS
    J Pathol; 1984 Apr; 142(4):293-9. PubMed ID: 6716213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myopathies in chronic renal failure patients on dialysis].
    Henning HV
    Dtsch Med Wochenschr; 1996 Jan; 121(4):115. PubMed ID: 8631240
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathophysiology and treatment of renal osteodystrophy].
    Ionova D
    Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronological study of signs of myoclonic encephalopathy in hemodialysis patients (author's transl)].
    Vecchierini-Blineau MF; Thebaud HE; Dupouet L; Brochard D; Coville P; Feve JR; Guiheneuc P
    Sem Hop; 1981 Nov 18-25; 57(43-44):1823-30. PubMed ID: 6274030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
    Wills MR; Savory J
    Lancet; 1983 Jul; 2(8340):29-34. PubMed ID: 6134894
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperparathyroidism and anemia in chronic renal failure.
    Geary DF; Fennell RS; Braylan RC; Iravani A; Garin EH; Richard GA
    Eur J Pediatr; 1982 Dec; 139(4):296-8. PubMed ID: 7182188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis encephalopathy. Clinical, electroencephalographic and interventional aspects.
    O'Hare JA; Callaghan NM; Murnaghan DJ
    Medicine (Baltimore); 1983 May; 62(3):129-41. PubMed ID: 6341757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.